Ipsos accelerates its digitisation of data collection in India with the acquisition of Crownit

Udgivet den 16-05-2024  |  kl. 15:45  |  

Ipsos accelerates its digitisation of data collection in India with the acquisition of Crownit

Paris, May 16, 2024 - Ipsos, one of the world's leading market research companies, announces the acquisition of Crownit. This company provides a mobile and online panel and data collection platform, giving access to India's largest community of consumers across 40 cities.

Crownit's mobile-first strategy empowers Ipsos to digitize a large part of its offline research capabilities, leveraging India's increasing mobile penetration to reach a broader spectrum of socioeconomic groups. This approach enhances digital sample representativeness, resulting in faster, high-quality data collection and improved efficiency.

Ben Page, Chief Executive Officer of Ipsos, commented: "This acquisition marks a significant step in expanding Ipsos India's data collection capabilities, by shifting from traditional offline methods to a more agile and efficient online approach, and by improving data quality and security. It supports our growth in India, enabling us to reach a wider audience and to gather more robust insights for our clients."

Sameer Grover, Chief Executive Officer of Crownit, added: Joining the Ipsos family is an important milestone for our company. We are excited to leverage our mobile-first platform and expertise to enhance Ipsos' data collection capabilities and support their vision of the future of market research in India. We are excited to serve our clients with combined strengths of Ipsos and Crownit".

Crownit's end-to-end ecosystem streamlines data collection processes, while advanced features will provide Ipsos with a competitive edge in the market research industry locally.

Finally, this acquisition complements Ipsos' existing online panel, iSay, by increasing online reach and representation in India. It will provide clients with access to a more diverse and representative pool of respondents, ultimately leading to richer and more actionable market intelligence.

ABOUT IPSOS

Ipsos is one of the largest market research and polling companies globally, operating
in 90 markets and employing nearly 20,000 people.

Our passionately curious research professionals, analysts and scientists have built unique multi-specialist capabilities that provide true understanding and powerful insights into the actions, opinions and motivations of citizens, consumers, patients, customers or employees. Our 75 business solutions are based on primary data from our surveys, social media monitoring, and qualitative or observational techniques.

"Game Changers" - our tagline - summarizes our ambition to help our 5,000 clients navigate with confidence our rapidly changing world.

Founded in France in 1975, Ipsos has been listed on the Euronext Paris since July 1, 1999. The company is part of the SBF 120, Mid-60 indices, STOXX Europe 600 and is eligible for the Deferred Settlement Service (SRD).
ISIN code FR0000073298, Reuters ISOS.PA, Bloomberg IPS:FP
www.ipsos.com

35 rue du Val de Marne
75 628 Paris, Cedex 13 France
Tel. +33 1 41 98 90 00

Attachment

Press release - Ipsos - Crownit acquisition - 160524 - EN

\Hugin

Udgivet af: NPinvestordk

Seneste nyheder

17:46 Europa/lukning: RFK som USA's sundhedsminister var gift for medicinalaktierne
17:07 Fredagens aktier: Nedtur til medicinalaktierne trak C25 i laveste niveau i år
17:00 Fredagens obligationer: Renten hoppede på stedet trods stærke tal fra USA
15:52 Forventninger dæmpes: Nu kun "fifty-fifty" om Fed sænker renten i december
15:39 USA/åbning: Kommentar fra Powell om renteudsigterne presser aktierne
15:08 Tørlastindekset Baltic Dry stiger for ottende gang på ni dage
14:00 USA/tendens: Powells rolige rentetilgang sender futures i rødt
13:55 DFDS-aktien i vejret efter alligevel at være kommet i mål med tyrkisk opkøb
13:16 Europa/aktier: Valg af vaccineskeptiker som USA's sundhedsminister tynger medicinal
13:14 DFDS køber alligevel tyrkisk virksomhed men på nye betingelser
13:07 SP Groups markante indtjeningsfremgang drevet af øget salg af egne varemærker
12:55 Trumps udnævnelse af kontroversiel sundhedsminister lægger pres på danske medicinalaktier
12:01 Obligationer/middag: Renten går et nøk ned inden amerikansk detailsalg
11:54 Aktier/middag: Bavarian får klø efter regnskab og kontroversielt ministervalg i USA
11:24 Efter en periode på sidelinjen anbefaler Danske Bank igen køb af NKT-aktien
11:12 Vi har rykket en del af julegaveindkøbene til andet kvartal siger MAtas-topchef
10:34 Bavarian Nordic løfter lidt af sløret for 2025: Har hentet ordrer for 2,4 mia. kr.
10:07 Topchef i Matas om omsætningsvækst: Flere nye varer, striber i Norden og hurtig levering
09:22 Bavarian dykker på bekymringer om 2025 og USA's nye sundhedsminister
09:20 Bavarian-aktie styrtdykker med 16 pct. efter regnskab og nyt fra USA